Clinical Trial Update: Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA) [Phase 4]

View source ↗

Summary

Pfizer-sponsored Phase 4 trial update reporting results for skin and soft tissue infections with suspected or proven MRSA; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Infection
• Skin and Soft Tissue Infections

Snippet

Sponsor: Pfizer | Conditions: Skin/Soft Tissue Infections, Methicillin Resistant Staphylococcus Aureus (MRSA) | Phase 4 | Status: COMPLETED | Results posted: 2012-08-08